Colinz Laboratories Intrinsic Value

Colinz Laboratories intrinsic value. Colinz Laboratories (COLINZ) median intrinsic value is ₹135.83 from 9 valuation models (range ₹60–₹207), vs current price ₹69.00 — +96.9% upside (Trading Below Calculated Value), margin of safety 49.2%. Analyse Colinz Laboratories ownership structure to track promoter, FII and institutional holdings.

Market Price (CMP)
₹69.00
Primary Intrinsic Value
₹207.00
Market Cap
₹20.7 Cr
+96.9% Upside
Median Value
₹135.83
Value Range
₹60 - ₹207
Assessment
Trading Below Calculated Value
Safety Margin
49.2%

COLINZ Valuation Methods Summary — DCF, Graham Number & P/E

Colinz Laboratories intrinsic value across 9 models vs current price ₹69.00 — upside/downside and value range per method. For current market price and key ratios, visit Colinz Laboratories share price today.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹207.00 ₹165.60 - ₹248.40 +200.0% EPS: ₹11.00, Sector P/E: 22x
Book Value Method asset ₹66.67 ₹60.00 - ₹73.34 -3.4% Book Value/Share: ₹33.33, P/B: 2.0x
Revenue Multiple Method revenue ₹60.00 ₹54.00 - ₹66.00 -13.0% Revenue/Share: ₹30.00, P/S: 2.0x
EBITDA Multiple Method earnings ₹133.33 ₹120.00 - ₹146.66 +93.2% EBITDA: ₹4.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹135.83 ₹108.66 - ₹163.00 +96.9% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹176.00 ₹158.40 - ₹193.60 +155.1% EPS Growth: 20.0%, Fair P/E: 16.0x
Growth Adjusted P/E growth ₹170.35 ₹153.31 - ₹187.39 +146.9% Revenue Growth: 6.5%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹138.00 ₹124.20 - ₹151.80 +100.0% ROE: 30.0%, P/E Multiple: 16x
Graham Defensive Method conservative ₹66.67 ₹60.00 - ₹73.34 -3.4% EPS: ₹11.00, BVPS: ₹33.33
Method Types: Earnings Asset DCF Growth Dividend Conservative

COLINZ Intrinsic Value vs Market Price — All Valuation Models

Colinz Laboratories fair value range ₹60–₹207 vs current market price ₹69.00 across 9 valuation models. Browse COLINZ income statement for revenue, profit, balance sheet and cash flow data.

COLINZ Intrinsic Value Analysis — Undervalued or Overvalued?

Colinz Laboratories median intrinsic value ₹135.83, current price ₹69.00 — Trading Below Calculated Value by 96.9%, margin of safety 49.2%.

What is the intrinsic value of COLINZ?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Colinz Laboratories (COLINZ) is ₹135.83 (median value). With the current market price of ₹69.00, this represents a +96.9% variance from our estimated fair value.

The valuation range spans from ₹60.00 to ₹207.00, indicating ₹60.00 - ₹207.00.

Is COLINZ undervalued or overvalued?

Based on our multi-method analysis, Colinz Laboratories (COLINZ) appears to be trading below calculated value by approximately 96.9%.

COLINZ Financial Health — Key Ratios vs Industry Benchmarks

Colinz Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 30.0% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 6.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.69x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

COLINZ Cash Flow Quality — Operating & Free Cash Flow

Colinz Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10
March 2025 ₹-2 Cr ₹-2 Cr Negative Cash Flow 3/10
March 2024 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10